Dr George R Simon, Professor of Medicine and Section Chief, Translational Research, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas talks about the SPORE programme for controlling lung cancer incidence and explains the role and impact of DNA repair pathways in therapeutic efficacy, in an interview with Viveka Roychowdhury.
India has a high burden of lung cancer. What are the causes specific to the country for this growing incidence?
About 1.8-2 million new lung cancer cases are estimated to occur globally, 6.9 per cent of which are from India. Globally, the disease is one of the commonest cancers and cause of cancer related deaths, and in India, lung cancer is the commonest cancer and cause of cancer related mortality in men.
Factors that are known to contribute to the growing incidence of lung cancer in India include smoking, bidi smoking, exposure to biomass fuel and environmental pollution. The incidence and pattern of lung cancer tend to differ with geographic region and ethnicity and largely reflect the prevalence and pattern of smoking in the country.
As the Section Chief, Translational Research, Department of Thoracic/Head and Neck Medical Oncology, what are the most promising areas of research to treat lung cancer?
Today, most research on lung cancer is focussed on areas of prevention, early detection and treatment. Promising lung cancer treatment options that have emerged include video assisted thoracic surgery (VATS) to treat small lung tumours, image guided radiation therapy (IGRT), newer combinations of chemotherapy drugs, immunotherapy and targeted therapy. Several new and exciting targeted therapies and immunotherapies have been approved in the last two years. These drugs have dramatically improved the lung cancer landscape. Newer treatment strategies evolve as resistance develops to existing treatments. Understanding these resistance treatments leads to the development of newer drugs to mitigate emerging mechanisms of resistance.
Could you give us more details of SPORE, the Specialized Program of Research Excellence programme and what hope does it offer lung cancer patients?
Denne historien er fra June 16, 2017-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra June 16, 2017-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Blissfill-Calibrated syringe pipettes for repetitive laboratory dosing as per ISO 8655-9
Blissfill syringe pipettes provide laboratories with an ergonomic, self-refilling solution for repetitive dosing, delivering precise volumes from 0.05ml to 10ml. With ISO 8655-9 compliance and an included calibration certificate, Blissfill ensures accuracy and ease of use for high-demand lab applications
Ensuring pharma compliance with testo data measurement technology
Comprehensive data measurement tools address regulatory demands and secure quality in pharma
Waters launches software for lab-centric business intelligence enabling audit readiness
waters_connect Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation
Ensuring clean room integrity with Prime Clean Reset High-Speed Doors
Designed with precision to meet the stringent requirements of controlled environments, Prime Clean Reset is the epitome of performance and reliability, ensuring that your clean room operations consistently meet the highest standards of regulatory compliance and product integrity
Optimising efficiency with Remote Laboratory Solutions
LabWare's comprehensive suite of software solutions designed specifically for laboratories offers reliable Remote Laboratory Solutions to help your business thrive in the current climate
Ensuring water quality with the 6000TOCi: The ultimate solution for continuous TOC measurement
The 6000TOCi Sensor is a comprehensive solution that brings together continuous monitoring, rapid response, reliability, and compliance
Enhancing pharmaceutical analysis in critical areas
Dheeraj Handique, Manager GC/GCMS Product Marketing, Shimadzu Analytical (India) highlights the benefits of GCMS-TQ8050 NX with HS-20 NX trap for genotoxic impurities, nitrosamines, and, extractables and leachables
Technical innovations for Annex 1
To meet the stringent EU GMP Annex 1 requirements, Optima presents innovative solutions to improve product and patient safety in pharmaceutical manufacturing. From minimising glove interventions and optimising First Air flow to advanced automation for integrity testing, this article explores how Optima's technologies support compliance in aseptic fill-and-finish processes
JRS Pharma - The Global MCC Manufacturing Network
JRS Pharma is one of the largest manufacturers of MCC across the globe. The know-how is based on more than 25 years of experience in development of own processes
Mack Pharmatech is the first to launch PLC-based environmental chambers in India
Manoj Choudhari, Managing Director, Mack Pharmatech shares insights on his company's pioneering expand globally and enhance regulatory compliance
